Factors associated with size of oedema extension distance in an adjusted multivariable regression model
| Coefficient | 95% CI | P value | |
| Female sex | 0.01 | −0.02 to 0.05 | 0.44 |
| Time event to CT | 0.18 | ||
| Day 1 (reference) | |||
| Day 2 | 0.07 | −0.008 to 0.14 | |
| Day 3 | 0.04 | −0.07 to 0.15 | |
| ICH location | <0.001 | ||
| Cerebellar (reference) | |||
| Brainstem | −0.08 | −0.21 to 0.06 | |
| Deep | 0.16 | 0.07 to 0.24 | |
| Lobar | 0.24 | 0.15 to 0.33 | |
| SBP (mm Hg) | 0.0002 | −0.0003 to 0.001 | 0.49 |
| OAC | 0.05 | −0.02 to 0.12 | 0.17 |
| Antihypertensive medication | −0.09 | −0.16 to −0.02 | 0.01 |
| Platelet level (x109/L) | 0.0002 | −0.00005 to 0.0004 | 0.11 |
| IV extension | −0.03 | −0.07 to 0.008 | 0.11 |
| HP CNV | 0.5 | ||
| HP1-1 | 0.03 | −0.02 to 0.09 | |
| HP2-1 | 0.01 | −0.03 to 0.05 | |
| HP2-2 (reference) | |||
| Rs2000999 | 0.93 | ||
| A:A (reference) | |||
| A:G | 0.01 | −0.09 to 0.11 | |
| G:G | 0.003 | −0.1 to 0.1 |
CNV, copy number variation; HP, haptoglobin; ICH, intracerebral haemorrhage;OAC, oral anticoagulation; SBP, systolic blood pressure.